CD79A and COVID-19: Our study exemplifies that RBD-expressing cell lines can be used to detect human IgG and IgA antibodies present in sera from COVID-19 convalescent patients and SARS-CoV-2 vaccinated individuals by multicolor flow cytometry (Figure 1A, right panel).